Leading future education with Adelaide University
A NEW major university is making its mark in Australia's prestigious 'Group of Eight' (Go8).
Adelaide University, opening in January 2026, recently debuted in the global top 100 in the latest 2026 QS World University Rankings.
Built on the collective expertise and achievements of the University of Adelaide and the University of South Australia, the new institution cements its place in the global top 1% as one of the best universities amongst more than 15,000 worldwide.
Research and industry-driven excellence
For over 151 years, the University of Adelaide has championed the pursuit of new knowledge – an enduring legacy reflected in its five Australian Nobel laureates and more than 100 Rhodes Scholars.
Its scientific discoveries include furthering the understanding of the space-time continuum as well as harnessing the nation's natural coastline to advance sustainable offshore energy production.
The University of South Australia, on the other hand, is Australia's university of enterprise, with innovation and industry deeply embedded in its education and research.
Its industry partnerships have produced Covid-19 detection drones at the height of the global pandemic and supported the production of the world's first shatterproof mirror.
Drawing on the legacies of these two universities, the newly formed Adelaide University's industry-driven degrees prepare students for jobs in emerging fields such as Artificial Intelligence (AI) while building a skilled workforce that will boost Malaysia's economy.
Curriculum for pioneers
South Australia has been a place of progress, where pioneers have made breakthroughs in antibiotics, clean energy, high-tech manufacturing and space.
At the centre of this enviable innovation ecosystem is the city's university sector.
With more than 400 in-demand degrees and 1500 new courses, Adelaide University builds a pipeline of global talent and ethical leaders in disciplines like Health and Biomedical Sciences, Business, Marketing and Management, Information Technology, and Communication and Media.
This includes a reimagined approach to work-integrated learning, offering more programme options and interdisciplinary courses that meet employers' demands.
Its distinctive curriculum design will support greater study flexibility, engagement and success for its students, equipping them with what's necessary to rise up to a rapidly evolving industry.
Adelaide University is among Australia's most industry-engaged universities and research partners of choice, backed by a Graduate Research School.
State-of-the-art facilities
Spanning the largest campus footprint in South Australia, Adelaide University boasts impressive and cutting-edge facilities.
This includes the AUD$247 million Adelaide Health and Medical Sciences Building, the first simulated financial trading room backed by industry software, and the recently established Responsible AI Research Centre that will support businesses in developing AI-enabled products and services.
Adelaide University conducts large-scale research that addresses a nation's critical needs. Through partnered research, it works across the full value chain, from translation to commercialisation.
Its ecosystem also includes the Ehrenberg-Bass Institute – the world's largest marketing research centre supporting global brands such as PepsiCo, BIC Corporate and LinkedIn – along with ThincLab and the Enterprise Hub, a space for entrepreneurs to breathe life into their ideas.
Study in one of the world's most liveable cities
Adelaide University sits within the stunning backdrop of Adelaide, ranked as the ninth most liveable city in the world by the Economist's Global Liveability Index 2025.
The capital's vibrant culture, safety and quality of life make it a global study destination of choice, becoming a hub for global talents.
Visit adelaideuni.edu.au or watch Adelaide University's story to learn more about the new Australian university.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
an hour ago
- The Star
Trump fires US labor official over data and gets earlier than expected chance to reshape Fed
WASHINGTON/NEW YORK (Reuters) -President Donald Trump on Friday fired a top Labor Department official on the heels of a market-shocking weak scorecard of the U.S. job market, accusing her without evidence of manipulating the figures and adding to already growing concerns about the quality of economic data published by the federal government. In a second surprise economic policy development, the door for Trump to make an imprint on a Federal Reserve with which he clashes almost daily for not lowering interest rates opened much earlier than anticipated when Fed Governor Adriana Kugler unexpectedly announced her resignation on Friday afternoon. The two developments further rattled a stock market already reeling from his latest barrage of tariff announcements and the weak jobs data. The benchmark S&P 500 Index sank 1.6% in its largest daily drop in more than two months. Trump accused Erika McEntarfer, appointed by former President Joe Biden, of faking the jobs numbers. There is no evidence to back Trump's claims of data manipulation by the Bureau of Labor Statistics, the statistical agency that compiles the closely watched employment report as well as consumer and producer price data. A representative for the BLS did not respond to a request for comment. Friday began with BLS reporting the U.S. economy created only 73,000 jobs in July, but more stunning were net downward revisions showing 258,000 fewer jobs had been created in May and June than previously reported. "We need accurate Jobs Numbers. I have directed my Team to fire this Biden Political Appointee, IMMEDIATELY. She will be replaced with someone much more competent and qualified," Trump said in a post on Truth Social. DATA CONCERNS A Trump administration official who requested anonymity said that while all economic data is noisy, the White House has been dissatisfied with how large the revisions have been in the recent data and issues with lower survey responses. The problem started during COVID and has not been addressed in the years since. "There are these underlying problems that have been festering here for years now that have not been rectified," the person said. "The markets and companies and the government need accurate data, and like, we just weren't getting that," the official said. The BLS has already reduced the sample collection for consumer price data as well as the producer price report, citing resource constraints. The government surveys about 121,000 businesses and government agencies, representing approximately 631,000 individual worksites for the employment report. The response rate has declined from 80.3% in October 2020 to about 67.1% in July, BLS data shows. A Reuters poll last month found 89 of 100 top policy experts had at least some worries about the quality of U.S. economic data, with most also concerned that authorities are not addressing the issue urgently enough. In addition to the concerns over job market data, headcount reductions at BLS have resulted in it scaling back the scope of data collection for the Consumer Price Index, one of the most important gauges of U.S. inflation, watched by investors and policymakers worldwide. Trump's move fed into concerns that politics may influence data collection and publication. "Politicizing economic statistics is a self-defeating act," said Michael Madowitz, principal economist at the Roosevelt Institute's Roosevelt Forward. "Credibility is far easier to lose than rebuild, and the credibility of America's economic data is the foundation on which we've built the strongest economy in the world. Blinding the public about the state of the economy has a long track record, and it never ends well." FED CHANGE SOONER THAN EXPECTED Meanwhile, Kugler's surprise decision to leave the Fed at the end of next week presents Trump an earlier-than-expected opportunity to install a potential successor to Fed Chair Jerome Powell on the central bank's Board of Governors. Trump has threatened to fire Powell repeatedly because the Fed chief has overseen a policymaking body that has not cut interest rates as Trump has demanded. Powell's term expires next May, although he could remain on the Fed board until January 31, 2028, if he chooses. Trump will now get to select a Fed governor to replace Kugler and finish out her term, which expires on January 31, 2026. A governor filling an unexpired term may then be reappointed to a full 14-year term. Some speculation has centered on the idea Trump might pick a potential future chair to fill that slot as a holding place. Leading candidates for the next Fed chair include Trump economic adviser Kevin Hassett, Treasury Secretary Scott Bessent, former Fed Governor Kevin Warsh and Fed Governor Chris Waller, a Trump appointee who this week dissented with the central bank's decision to keep rates on hold, saying he preferred to start lowering them now. Trump, as he was leaving the White House to spend the weekend at his Bedminster, New Jersey, estate, said he was happy to have the open slot to fill. "I would not read any political motivation into what [Kugler is] doing, although the consequence of what she's doing is she's calling Trump's bluff,"said Derek Tang, an analyst at LH Meyer, a research firm. "She's putting the ball in his court and saying, look, you're putting so much pressure on the Fed, and you want some control over nominees, well, here's a slot." (Additional reporting by Jasper Ward and Trevor Hunnicutt; Writing by Daniel Burns; Editing by Chris Reese and Nia Williams and Anna Driver)
New Straits Times
5 hours ago
- New Straits Times
Pfizer, BioNTech lose UK appeal to Moderna in Covid-19 vaccine patent fight
LONDON: US pharmaceutical giant Pfizer and German firm BioNTech lost Friday a court appeal in the latest step of a multi-million pound battle against US rival Moderna over the Covid-19 vaccine. The Appeals Court in London upheld an earlier UK court decision in the long-running battle between the global pharma firms. It found that one of the European patents held by Moderna was invalid, but that a second one had been broken by Pfizer and its German partner BioNTech. "The judge made no error of law or principle" in the ruling handed down in July 2024, the Appeal Court judges wrote Friday, dismissing the appeal brought by the two companies. Pfizer quickly said it will appeal Friday's ruling to Britain's Supreme Court. "Today's UK Court of Appeal's decision does not change our unwavering stance that this patent is invalid," Pfizer said in a statement. "This decision has no immediate impact on Pfizer and BioNTech." Pfizer and BioNTech had argued that both the patents cited by Moderna were invalid, and neither had been infringed. Friday's decision could have wide implications for other cases involving the huge pharma companies in the United States, Germany, Belgium, the Netherlands and Ireland. Moderna said in a statement it was pleased with Friday's ruling and would "continue to pursue and enforce its patent rights globally to protect its innovative mRNA technology." A UK court was told last year the firms had spent £19 million (US$25 million) fighting their legal battles. In 2020, Pfizer and BioNTech's vaccine became the first ever mRNA vaccine approved for widespread use, and was swiftly deployed to combat the Covid pandemic. Scientists believe mRNA vaccines, which provoke an immune response by delivering genetic molecules containing the code for key parts of a pathogen into human cells, could be a game-changer against many diseases. Traditional vaccines contain some form of the dead or inactivated target virus. Since the virus need not be grown in the lab, mRNA vaccines can in theory be developed at scale more quickly than traditional vaccines. In March, a German court in Duesseldorf also found Pfizer and BioNTech had violated a Moderna patent filed between 2010 to 2016 to make their vaccines. It ordered they must provide estimates of how much they had profited from breaking the patent as well as provide "appropriate compensation."--AFP
The Star
9 hours ago
- The Star
Tiny terror meets its match
Major pest: Aedes mosquitoes are the primary vectors of chikungunya.— AFP Scientists battling the country's largest chikungunya epidemic are releasing swarms of giant cannibal mosquitoes whose larvae devour the smaller insects spreading the debilitating disease. These so-called 'elephant mosquitoes', measuring nearly 2cm in length, are voracious predators. Public health experts hope these unusual allies will become unlikely heroes in stopping the painful, fast-moving virus in the southern province of Guangdong. With more than 6,000 infections reported in just three weeks in Foshan alone, authorities are also reviving familiar tactics from the Covid-19 playbook, including mass polymerase chain reaction testing, isolation of infected residents and neighbourhood-wide disinfection campaigns. Yet it's the unconventional methods – giant mosquitoes – that underscore the desperation of officials confronting an unprecedented outbreak. The larvae of these so-called elephant mosquitoes, also known as Toxorhynchites splendens, is released by a research team from Sun Yat-sen University's Zhongshan School of Medicine in Guangdong. They don't bite humans but prey on Aedes mosquitoes – the primary vectors of chikungunya, dengue, Zika and yellow fever. Foshan, a sprawling city in central Guangdong, is deploying another tool: a local variety of fish that eats mosquito eggs and larvae. More than 5,000 of the fish have been released into city ponds and rivers. The city has designated 53 hospitals for chikungunya treatment, offering more than 3,600 beds equipped with mosquito nets and plans to expand capacity, according to state broadcaster CCTV. In nearby Guangzhou, officials published a risk map of all 120 communities and launched a week-long campaign involving mosquito spraying twice a day. One larva of the elephant mosquito can consume up to 100 Aedes, according to Zhang Dongjing, associate professor and technical director of a 'mosquito factory' linked to Sun Yat-sen University. — Bloomberg
